Navigation Links
Two genes together drive aggressive prostate cancer
Date:5/12/2014

NEW YORK, NY (May 12, 2014) Two genes work together to drive the most lethal forms of prostate cancer, according to new research from the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center (CUMC). These findings could lead to a diagnostic test for identifying those tumors likely to become aggressive and to the development of novel combination therapy for the disease.

The two genesFOXM1 and CENPFhad been previously implicated in cancer, but none of the prior studies suggested that they might work synergistically to cause the most aggressive form of prostate cancer. The study was published today in the online issue of Cancer Cell.

"Individually, neither gene is significant in terms of its contribution to prostate cancer," said co-senior author Andrea Califano, PhD, the Clyde and Helen Wu Professor of Chemical Biology in Biomedical Informatics and the Institute for Cancer Genetics and chair of systems biology at Columbia's College of Physicians and Surgeons. "But when both genes are turned on, they work together synergistically to activate pathways associated with the most aggressive form of the disease."

"Ultimately, we expect this finding to allow doctors to identify patients with the most aggressive prostate cancer so that they can get the most effective treatments," said co-senior author Cory Abate-Shen, PhD, the Michael and Stella Chernow Professor of Urologic Sciences and professor of pathology and cell biology at CUMC. "Having biomarkers that predict which patients will respond to specific drugs will hopefully provide a more personalized way to treat cancer."

Scientists widely recognize that cancer is characterized by multiple genetic changes. "However, distinguishing the handful of genes that are driving the cancer from the many genes whose altered expression does not contribute directly to the cancer has proven to be a daunting task," said Dr. Califano. "It becomes even more d
'/>"/>

Contact: Karin Eskenazi
ket2116@cumc.columbia.edu
212-342-0508
Columbia University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Environmental factors as important as genes in understanding autism
2. Novel analyses improve identification of cancer-associated genes from microarray data
3. A civil war inside our cells: Scientists show how our bodies fight off jumping genes
4. Two genes linked to inflammatory bowel disease
5. Low tolerance for pain? The reason may be in your genes
6. Splice variants reveal connections among autism genes
7. CAMH researcher discovers 2 new genes linked to intellectual disability
8. Novel genes determine division of labor in insect societies
9. New clues may link hereditary cancer genes to increased risk of cancer from alcohol
10. Testosterone-regulated genes may affect vaccine-induced immunity
11. Study identifies protein that helps developing germ cells wipe genes clean of past imprints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... ANGELES (PRWEB) May 27, 2015 Readers ... processes may find help in author Chester Litvin ... Psychoconduction : Litvin’s Code” (published by Trafford Publishing). , ... new approach for stimulating the brain. This book will ... to reeducate their sensory brain cells . He ...
(Date:5/26/2015)... May 27, 2015 This summer, ChopChop: ... with local communities at key events in Greater Boston with ... with free copies of ChopChop Magazine, healthy snacks and other ... stay active. , “We want to get our message of ... in a memorable and fun way,” explains Sally Sampson, Founder ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 In God’s ... with her as she writes an unforgettable story of ... in her life. The first black student to desegregate ... and beaten by some students, treated harshly by a ... A motivating personal phone conversation with Dr. Martin Luther ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Dermatologic surgeons ... in 2014, according to survey results released today by ... in skin cancer treatments and several cosmetic categories, 2014 ... but remained steady overall compared to 2013 figures. ... cancer treatments ranked as the most-performed procedure (3.08 million) ...
(Date:5/26/2015)... 2015 The federal court overseeing more ... behalf of individuals who were allegedly injured by the ... Science Day. According to an Order issued in the ... 21st, topics to be addressed include Xarelto adverse events, ... blood test based testing with Xarelto, and Xarelto pharmacology. ...
Breaking Medicine News(10 mins):Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 3Health News:Award-Winning Cooking Magazine for Kids Takes Healthy Cooking and Eating to the Streets with One-of-a-Kind Bike Campaign 2Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 4Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4
... State ... Medical Center ... Clinical Trial TUSTIN, Calif. and SYDNEY, April 22 ... heart assist technologies, announced today that The Ohio State University Medical ...
... Parks to hold second annual Walk-a-thon event THIS SUMMERNEW YORK, ... Six Flags, and Cure Kids Cancer have teamed up once ... its "A Walk In The Park" program. This unique ... properties April 26 through July 26 offering local neighborhoods a ...
... Smokefree Laws, Three plus DC Raised Tobacco Taxes--WASHINGTON, April 22 ... Lung Association, 2008 proved to be a slow year for ... select few taking the steps that are needed to curb ... update of State Legislated Actions on Tobacco Issues ...
... BILTHOVEN and NIJMEGEN, The Netherlands, April 22 ... Medical Centre have entered,into a research agreement ... , Under the ... Experimental Urology), InteRNA,s unique lentiviral-based miRNA,overexpression library ...
... a week, , , WEDNESDAY, April 22 (HealthDay News) -- Men ... to have a reduced risk of heart failure, a new ... Swedish researchers followed nearly 40,000 Swedish men, ages 45 to ... outcomes. During that time, 597 men with no history of ...
... Together to Ask President Obama for a Greater Voice in the ... ... April 22, 2009 -- In recent days, both conservative and liberal ... in the healthcare reform debate. Understanding that President Obama has ...
Cached Medicine News:Health News:Video: U.S. Announcement - First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 2Health News:Video: U.S. Announcement - First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 3Health News:Video: U.S. Announcement - First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 4Health News:Six Flags Friends Invites Guests to Help Cure Kids Cancer by Taking 'A Walk In The Park' 2Health News:Six Flags Friends Invites Guests to Help Cure Kids Cancer by Taking 'A Walk In The Park' 3Health News:Six Flags Friends Invites Guests to Help Cure Kids Cancer by Taking 'A Walk In The Park' 4Health News:New American Lung Association Report Reveals States Failing to Enact Lifesaving Tobacco Control Policies 2Health News:New American Lung Association Report Reveals States Failing to Enact Lifesaving Tobacco Control Policies 3Health News:InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer 2Health News:Fatty Fish May Cut Heart Failure Risk in Men 2Health News:Millennials Push For Seat at the Table on Healthcare Reform 2
(Date:5/26/2015)... , May 26, 2015  AbbVie (NYSE: ... Phase 3 GIFT-I study of its investigational, all-oral, ... treatment with ombitasvir/paritaprevir/ritonavir at the Annual Meeting of ... Japan . 1 GIFT-I evaluated ... infected Japanese patients, with and without cirrhosis, who ...
(Date:5/26/2015)... -- XRpro Sciences, Inc., a provider of a unique platform for ... and ion channel assays for the pharmaceutical industry, announced today ... MicroCap Conference on Thursday, May 28, 2015 in ... Hotel. The Company,s presentation by Richie Cunningham ... to begin at 1:30 p.m ET. Click here to view ...
(Date:5/26/2015)... , England and PITTSBURGH , May 26, ... leading global pharmaceutical company, today announced that Mylan CEO ... Bernstein Strategic Decisions Conference, Friday, May 29, 2015 at ... access a live webcast of the presentation via the ... . An archived version will also be available following ...
Breaking Medicine Technology:AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6XRpro Sciences, Inc. To Present at 2015 Marcum MicroCap Conference 2
... Families of Spinal Muscular Atrophy announced today that Repligen ... Administration to commence a Phase I safety study in healthy ... for Spinal Muscular Atrophy. FSMA began the ... drug development, when risk is the highest.  It was the ...
... BD (Becton, Dickinson and Company) (NYSE: ... today the publication of its 2010 Sustainability Report ... dedicated associates worldwide to pursuing the Company,s purpose, " ... so in a way that is centered on balancing ...
Cached Medicine Technology:Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 2Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 3BD Issues 2010 Sustainability Report 2BD Issues 2010 Sustainability Report 3
... The High Throughput Sorter RSD ... high volume laboratories in the field ... is not only of considerable speed ... optional Recapping Module can be integrated. ...
... System RCS 800 closes various plastic primary and ... way. Different tube heights and diameters can be ... be used for send-outs. The integration into other ... System RSD 800 and High Throughput Sorter RSD ...
... Decapping System DS 800 selectively removes closures from ... the barcode towards the rack opening in one ... integrated in PVT Systems like Sorting System RS ... Sorter RSD ProVolume and Aliquoting System RSD 800A. ...
... Nanogen offers reagents to detect sequences ... parainfluenza virus 1, 2 and 3; ... respiratory syncytial virus A and B. ... to create homebrew tests., ...
Medicine Products: